This study assessed whether cytoskeletal protein alpha-II spectrin breakdown products
(SBDP150, SBDP145, and SBDP120) would identify the presence of aSAH and be …

Object Aneurysmal subarachnoid hemorrhage (ASAH) is a serious event with grave
consequences. Delayed ischemic neurological deficits caused by cerebral arterial …

Biomarkers for neurodegeneration could be early prognostic measures of brain damage and
dysfunction in aneurysmal subarachnoid hemorrhage (aSAH) with clinical and medical …

Objectives Serum neurofilament light chain (NfL) is a biomarker for neuroaxonal damage,
and S100B is a blood marker for cerebral damage. In the present study, we investigated the …

In this study we assessed the clinical utility of quantitative assessments of αII-spectrin
breakdown products (SBDP145 produced by calpain, and SBDP120 produced by caspase …

Aneurysmal subarachnoid haemorrhage (aSAH) is a serious condition with a high mortality
and high permanent disability rate for those who survive the initial haemorrhage. The …

Abstract αII-spectrin breakdown products are regarded as potential biomarkers for traumatic
brain injury (TBI). The aim of the present study was to further evaluate these biomarkers by …

Poor outcomes of aneurysmal subarachnoid hemorrhage (aSAH) can be the result of the
initial catastrophic event or the many acute or delayed neurological complications. Recent …

Objective Despite advances in the treatment of aneurysmal subarachnoid hemorrhage
(aSAH) one-year mortality remains approximately 50%. Making an accurate prognosis at the …

Aim To investigate the correlation of serum changes and markers of brain injury (BI) in
cerebrospinal fluid (CSF) with postoperative cognitive dysfunction (POCD) in patients with …